Literature DB >> 3220102

Activation of rat complement by soluble and insoluble rat IgA immune complexes.

M Rits1, P S Hiemstra, H Bazin, L A Van Es, J P Vaerman, M R Daha.   

Abstract

The ability of rat monoclonal IgA, specific for 2,4-dinitrophenyl (DNA), to activate the complement (C) system of the rat was investigated using aggregated IgA or IgA immune complexes (IC). IgA was coated onto a solid phase, and tested for its capacity to bind C3 upon incubation at 37 degrees C in normal rat serum (NRS) in the presence of Mg-EGTA. Binding of C3 was observed dependent on the dose of dimeric (d-), polymeric (p-) and secretory IgA tested. In contrast, little C3 fixation was observed in this system with monomeric (m-) rat IgA or with mouse m- and d-IgA (MOPC315). Soluble and insoluble rat IgA IC were prepared using dinitrophenylated rat serum albumin (DNP8RSA) as antigen (Ag), and assessed for C activation. It was shown that insoluble IC (immune precipitates; IP) containing m-, d- or pIgA of rat origin activate the alternative pathway of rat C, as demonstrated by their capacity to induce C consumption in NRS in the presence of Mg-EGTA. When p- and m-IgA IP were compared for their capacity to activate C, it was found that p-IgA activated C four times as efficiently as m-IgA IP (at 2 mg/ml). Soluble rat IgA IC were prepared in an excess of DNP8RSA, fractionated by gel filtration on Sepharose 6B, and analyzed for C activation and antibody (Ab)/Ag ratio. In contrast to m-IgA IP, soluble m-IgA did not activate C. On the other hand soluble d-IgA IC activated C dependent on their concentration and size: at a concentration of 0.1 mg/ml high-molecular weight d-IgA IC with a high Ab/Ag ratio were four times as efficient as low-molecular weight IC with a low Ab/Ag ratio, and twice as efficient as IP prepared at equivalence. To demonstrate the induction by IgA of the assembly of the terminal membrane attack complex, trinitrophenyl (TNP)-conjugated rat red blood cells (TNP-RRBC) coated with d- or p-IgA were shown to be lysed in NRS in the presence of Mg-EGTA. No lysis of m-IgA-coated TNP-RRBC was observed. The results in this study demonstrate that both soluble and insoluble rat IgA IC activate the alternative pathway of homologous rat C. Alternative pathway activation by soluble rate IgA IC is dependent on the size of the IC. The degree of polymerization of the IgA Ab itself also influences C activation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3220102     DOI: 10.1002/eji.1830181202

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  7 in total

Review 1.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

Review 2.  Oral microbial ecology and the role of salivary immunoglobulin A.

Authors:  H Marcotte; M C Lavoie
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

3.  Significance of rheumatoid factor isotypes in seronegative rheumatoid arthritis.

Authors:  F Eggelmeijer; H G Otten; H H de Rooy; M R Daha; F C Breedveld
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

4.  Fc receptor function and circulating immune complexes in gluten sensitive enteropathy--possible significance of serum IgA.

Authors:  B Lavö; B Nilsson; L Lööf; U R Nilsson; K N Ekdahl
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

5.  An acute model for IgA-mediated glomerular inflammation in rats induced by monoclonal polymeric rat IgA antibodies.

Authors:  R K Stad; J A Bruijn; D J van Gijlswijk-Janssen; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

6.  In vivo activation of complement by IgA in a rat model.

Authors:  R K Stad; W M Bogers; M E Thoomes-van der Sluys; L A Van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

7.  Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection.

Authors:  Kazunori Murata; William M Baldwin
Journal:  Transplant Rev (Orlando)       Date:  2009-04-10       Impact factor: 3.943

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.